Earlier today, the actuarial firm of Milliman, Inc. released their annual Medical Index for 2015 – an index that they’ve calculated and published since 2001. The Milliman Medical Index (MMI) is the total annual cost of healthcare as estimated by Milliman for a typical family of four with employer-provided PPO insurance coverage.  According to Milliman, this […]

(Reuters Health) – Cholesterol-lowering drugs such as statins may reduce the risk of stroke in low-risk elderly patients, a French study suggests. People who took statins or fibrates, another type of cholesterol-lowering medicine, were 34 percent less likely to have a stroke than those who didn’t, researchers report. “If confirmed, these results are compatible with […]

Novo Nordisk is looking into recent clinical trial data that show its diabetes drug Victoza has potential as a treatment for fatty liver disease, a hot area for pharmaceutical development. Research from Britain’s University of Birmingham showed last month that the drug, also known as liraglutide, resolved fatty liver disease in more than a third […]

The headquarters of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, in this file photo taken on November 4, 2009. Reuters/Jason Reed The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drugs sold by AstraZeneca, Johnson & Johnson and Eli […]

The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drugs sold by AstraZeneca, Johnson & Johnson and Eli Lilly in partnership with Boehringer Ingleheim may cause dangerously high levels of blood acids that could require hospitalization. The drugs belong to a class known as SGLT2 […]

India’s Supreme Court has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck’s diabetes drugs Januvia and Janumet, according to a court document released on Friday. The court has, however, allowed Glenmark to continue to sell existing inventory, according to the document posted on the Supreme Court’s website after a hearing. The […]

NORTH CHICAGO, Ill., May 15, 2015 /PRNewswire/ — AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has granted HUMIRA® (adalimumab) orphan drug designation for the investigational treatment of moderate-to-severe hidradenitis suppurativa (HS) (Hurley Stage II and Hurley Stage III disease), a painful, chronic inflammatory skin disease. AbbVie’s supplemental Biologic License Application seeking […]

In the five years since the first DrugBaron article was published, entitled “Hard Times, Harder Times,” it seems that in the business of drug discovery and development everything has changed – and at the same time nothing. On the one hand, the ubiquitous gloom that surrounded the industry has lifted, to be replaced with a febrile […]

Shares in Orexigen Therapeutics, the maker of a weight-loss drug called Contrave, have dropped 24%  to $5 since Tuesday, when news came out that data that the drug maker had originally presented as showing Contrave prevented heart attacks and strokes were part of a study that, in the end, showed no such thing. The news was […]

A simple daily vitamin may help prevent the most common types of skin cancer in people at high risk of the disease, according to new research from Australia. A study conducted at the University of Sydney found that nicotinamide, a form of vitamin B3, reduced by 23 percent the incidence of new, non-melanoma skin cancers […]